•  
  •  
  •  
  •  

2026-05-23 21:27:13

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Prithvi Exchange India Ltd announces financial performance for the 4th quarter ended March 31, 2026
  • SMS Pharmaceuticals Reports Robust FY26 Performance: PAT Soars 48% and EBITDA Margins Expand to 19%
  • NBCC India Ltd secures 2 orders worth Rs. 42.55 crores
  • Icon Facilitators Limited receives order worth Rs. 2.69 crore
  • Fabtech Technologies Cleanrooms Ltd receives order worth Rs. 65.10 crores

Keywords Selected:  Biotech

IPO News

  • Concord Biotech Limited's IPO to open on Friday, 4th August, 2023, sets price band at ₹705 to ₹741 per Equity Share
  • Windlas Biotech Ltd posts consolidated PAT of Rs. 11.44 crores in Q4FY23
  • Ahmedabad-based Concord Biotech gets SEBI nod for IPO
  • Rare Enterprises and Quadria Capital-backed Concord Biotech files DRHP for IPO

Stock Report

  • Rossari Biotech Ltd consolidated Q4 FY2026 PAT climbs to Rs. 45.96 crores
  • Rossari Biotech Ltd recommends final dividend of Rs. 0.50
  • Windlas Biotech Announces ₹47 Crore Share Buyback at ₹1,000 per Share
  • Indrayani Biotech Limited Finalizes Terms for ₹49.90 Crore Rights Issue
  • Unitop Chemicals Pvt Ltd commissions 15000 MTPA ethoxylation capacity
  • Modi Biotech Pvt Ltd commissions commercial operations of ethanol plant
  • Indo US Bio-Tech Ltd Q3 FY2025-26 net profit lower at Rs. 2.99 crore
  • Rossari Biotech Ltd Q3FY26 consolidated profit at Rs. 32.77 crores
  • Medicamen Biotech Ltd gets EU approval for Paracetamol from Danish Medicine Authority
  • Vivo Bio Tech Ltd receives GLP compliance from NGCMA
  • Titan Biotech Ltd fixes Feb 20, 2026 as record date for 5:1 stock split
  • Fermenta ranked among India's Best Workplaces™ in Pharmaceuticals, Healthcare & Biotech by Great Place to Work®
  • Fermenta Board approves INR 110 Crore Capex at Dahej for Plant-based Vitamin D3, Green Chemistry Enzyme, and Vitamin D3 Derivatives
  • Coastal Biotech Pvt Ltd receives allocation for Supply of Ethanol to OMC's under Ethanol Blended Petrol Programme
  • Rossari Biotech Ltd Q2 FY2025-26 consolidated PAT increases to Rs. 36.87 crores
  • Concord Biotech Ltd completes NAFDAC inspection successfully
  • Fermenta Biotech Limited Certified as a Great Place to Work®
  • Fermenta Board approves sale of Environmental Solutions Business to Wholly Owned Subsidiary
  • Fermenta Granted Process Patent for Plant-Based Vitamin D3
  • Concord Biotech Limited completes EUGMP inspection at its API facility
  • Vivo Bio Tech Ltd secures landmark Pre-Clinical Testing Contract Valued at ₹10.75 Crores
  • Fermenta announces Granting of CEP by EDQM for VITADEE™ 100 SD, Enabling Accelerated Global Growth
  • Concord Biotech Ltd successfully completes Russian GMP insepction at its API facility
  • Shilpa Medicare Backs US Biotech Alveolus Bio to Accelerate Next‐Gen Lung Disease Therapies

Latest Post

  • Prithvi Exchange India Ltd announces financial performance for the 4th quarter ended March 31, 2026
  • SMS Pharmaceuticals Reports Robust FY26 Performance: PAT Soars 48% and EBITDA Margins Expand to 19%
  • NBCC India Ltd secures 2 orders worth Rs. 42.55 crores
  • Icon Facilitators Limited receives order worth Rs. 2.69 crore
  • Fabtech Technologies Cleanrooms Ltd receives order worth Rs. 65.10 crores


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025